Fetal Growth Restriction, USCOM
Conditions
Brief summary
The purpose of this research study is to study the use of an ultrasound measurement system (USCOM) for patients with newly diagnosed fetal growth restriction (FGR). This system uses a technology to measure how much blood is being pumped in and out of the heart, which is important for understanding the heart's function in relation to pregnancy.
Interventions
DEVICEUSCOM
Device that measures how much blood is being pumped in and out of the heart.
Sponsors
Icahn School of Medicine at Mount Sinai
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Pregnant patients with a new diagnosis of fetal growth restriction (estimated fetal weight \<10th percentile or abdominal circumference \<10th percentile) in the third trimester (gestational age \>27w6d)
Exclusion criteria
* Multiple gestation * Fetal anomalies * Gestational diabetes or pregestational diabetes.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Systemic vascular resistance obtained from USCOM | every 2-4 weeks at time of prenatal ultrasound, until the end of pregnancy | Cardiac output related to systemic vascular resistance (SVR) obtained from the USCOM device. SVR is an indicator of general resistance experienced within the circulatory system and is correlated with an array of cardiac related adverse health outcomes. The USCOM device uses noninvasive ultrasonographic technology to determine SVR at the time of prenatal ultrasound. |
Countries
United States
Contacts
STUDY_DIRECTORNicola F Tavella, MPH
Icahn School of Medicine at Mount Sinai
PRINCIPAL_INVESTIGATORRachel J Meislin, MD
Icahn School of Medicine at Mount Sinai
Outcome results
None listed